About Simergent
Simergent is a company based in Chicago (United States) founded in 2014. Simergent has raised $11.84 million across 4 funding rounds from investors including HHS and i2E. Simergent offers products and services including Archimedes System. Simergent operates in a competitive market with competitors including AWAK, Peripal, Relavo, liberDi and GlomeriaTherapeutics, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.84 M (USD)
in 4 rounds
-
Latest Funding Round
$7.8 M (USD), Series A
Mar 29, 2024
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Simergent
Simergent offers a comprehensive portfolio of products and services, including Archimedes System.
Automated peritoneal dialysis device for safe home use and reduced complications.
Funding Insights of Simergent
Simergent has successfully raised a total of $11.84M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $7.8 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Simergent
Simergent has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and i2E.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & Angel networks focused on science and tech startups
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Simergent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Simergent
Investment portfolio details for Simergent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Simergent
Detailed financials for Simergent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Simergent Comparisons
Peer comparison for Simergent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Simergent
Simergent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AWAK, Peripal, Relavo, liberDi and GlomeriaTherapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops innovative portable digital dialysis devices for healthcare.
|
|
| Locked | Locked | Locked |
Develops innovative home-based devices for peritoneal dialysis treatments.
|
|
| Locked | Locked | Locked |
Development of dialysis devices for kidney failure patients is conducted.
|
|
| Locked | Locked | Locked |
Portable peritoneal dialysis systems are developed for end-stage kidney patients.
|
|
| Locked | Locked | Locked |
Medical devices for nephropathy and cardiopathy treatments are developed.
|
Detailed competitors of Simergent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Simergent
Complete news archive for Simergent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simergent
Simergent was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Simergent is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Simergent is a funded company, having raised a total of $11.84M across 4 funding rounds to date.
Simergent was founded in 2014 and is based in Chicago, United States. Automated peritoneal dialysis devices are developed for home application in end-stage renal disease treatment. Products are exported to markets including Mexico, China, India, and others. Operations are conducted within the medical device sector, focusing on renal care solutions.
Simergent's top competitors include liberDi, Padmaseetha Technologies and Avyantra.
Simergent offers Archimedes System.